dc.contributor.author | Sandler, CX | |
dc.contributor.author | Wyller, VBB | |
dc.contributor.author | Moss-Morris, R | |
dc.contributor.author | Buchwald, D | |
dc.contributor.author | Crawley, E | |
dc.contributor.author | Hautvast, J | |
dc.contributor.author | Katz, BZ | |
dc.contributor.author | Knoop, H | |
dc.contributor.author | Little, P | |
dc.contributor.author | Taylor, R | |
dc.contributor.author | Wensaas, KA | |
dc.contributor.author | Lloyd, AR | |
dc.date.accessioned | 2021-12-02T05:40:41Z | |
dc.date.available | 2021-12-02T05:40:41Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 2328-8957 | |
dc.identifier.doi | 10.1093/ofid/ofab440 | |
dc.identifier.uri | http://hdl.handle.net/10072/410493 | |
dc.description.abstract | Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed "long-COVID"), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16-20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%-35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. | |
dc.language | en | |
dc.publisher | Oxford University Press (OUP) | |
dc.relation.ispartofissue | 10 | |
dc.relation.ispartofjournal | Open Forum Infectious Diseases | |
dc.relation.ispartofvolume | 8 | |
dc.subject.fieldofresearch | Virology | |
dc.subject.fieldofresearch | Immunology | |
dc.subject.fieldofresearchcode | 310706 | |
dc.subject.fieldofresearchcode | 3204 | |
dc.title | Long COVID and post-infective fatigue syndrome: A review | |
dc.type | Journal article | |
dc.type.description | C2 - Articles (Other) | |
dcterms.bibliographicCitation | Sandler, CX; Wyller, VBB; Moss-Morris, R; Buchwald, D; Crawley, E; Hautvast, J; Katz, BZ; Knoop, H; Little, P; Taylor, R; Wensaas, KA; Lloyd, AR, Long COVID and post-infective fatigue syndrome: A review, Open Forum Infectious Diseases, 2021, 8 (10) | |
dcterms.license | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.date.updated | 2021-12-02T05:18:18Z | |
dc.description.version | Version of Record (VoR) | |
gro.rights.copyright | © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/ licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Sandler, Carolina X. | |